• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Topics in Mediator Pharmacology

Topics in Mediator Pharmacology

9781616689612
415,74 zł
374,16 zł Zniżka 41,58 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 374,16 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
Pharmacology can be defined as a discipline of paramedical sciences that teaches how the use of drugs can bring about changes from pathological states to physiological conditions. Whereas mediator pharmacology is a subdivision pharmacology which teaches the functions of molecules released in the body and produces profound pharmacological effects. Also, their sustained release may results in pathological conditions. The agonists or antagonists of these mediators may offer novel therapeutic agents for clinical benefits. This book provides necessary scientific developments in mediator pharmacology.
Szczegóły produktu
73481
9781616689612
9781616689612

Opis

Rok wydania
2011
Numer wydania
1
Oprawa
twarda
Liczba stron
191
Wymiary (mm)
230.00 x 155.00
Waga (g)
558
  • Preface; Pathogenic Responses of Bradykinin System in Chronic Inflammatory Rheumatoid Disease; Interrelationship between the kallikrein-kinin system & hypertension; The Role of Chemical Mediators in the Pathogenesis of Inflammation with Emphasis on the Kinin System; Mediation of Kallikrein-kinin system in the mechanism of action of angiotensin converting enzyme inhibitors; The Kinin System & Prostaglandins in the Intestine; Proinflammatory actions of the platelet activating factor:: Relevance to rheumatoid arthritis; Role of Tissue Kallikrein-Kininogen-Kinin Pathways in the Cardiovascular System; Role of Nitric Oxide in Inflammatory Diseases; The role of leukotrienes in the pathophysiology of inflammatory Disorders:: Is there a case for revisiting leukotrienes as therapeutic targets?; Therapeutic prospects for bradykinin receptor agonists in the treatment of cardiovascular diseases; Therapeutic prospects of bradykinin receptor antagonists; Index.
Komentarze (0)